These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 14572601)

  • 1. Chronic viral hepatitis, interferon, diabetes mellitus, and celiac disease.
    Narváez I; Pérez B; del Mar Alcalde M; Jiménez C; Soria A
    Am J Gastroenterol; 2003 Oct; 98(10):2336-7. PubMed ID: 14572601
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chronic viral hepatitis: guidelines for diagnosis and therapy. When to treat--when wait?].
    Füessl HS
    MMW Fortschr Med; 2000 Oct; 142(42):10-1. PubMed ID: 11077820
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of chronic viral hepatitis].
    Pedersen C; Pedersen CR
    Ugeskr Laeger; 2008 Jun; 170(24):2137-40. PubMed ID: 18565297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon and ribavirin treatment for chronic hepatitis C may activate celiac disease.
    Adinolfi LE; Durante Mangoni E; Andreana A
    Am J Gastroenterol; 2001 Feb; 96(2):607-8. PubMed ID: 11232725
    [No Abstract]   [Full Text] [Related]  

  • 5. Late development of diabetes mellitus after interferon-alfa and ribavirin therapy for chronic hepatitis C: a case report.
    Radhakrishnan S; Upadhyay A; Mohan N; Dhar A; Walia HK; Zubaidi G
    Med Princ Pract; 2005; 14(4):281-3. PubMed ID: 15961942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vogt-Koyanagi-Harada disease associated with interferon-A and ribavirin therapy for chronic hepatitis C infection.
    Papastathopoulos K; Bouzas E; Naoum G; Vergados I; Tsiodras S
    J Infect; 2006 Feb; 52(2):e59-61. PubMed ID: 15951019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chronic viral hepatitis B and C. Hysteria and panic are no longer appropriate].
    Schwerdtfeger M; Fleig WE
    MMW Fortschr Med; 2000 Nov; 142(46):39-42. PubMed ID: 11132310
    [No Abstract]   [Full Text] [Related]  

  • 8. [Onset of type 1 diabetes mellitus during combination therapy of chronic hepatitis C with interferon-alpha and ribavirin].
    Christensen UB; Krogsgaard K
    Ugeskr Laeger; 2004 Mar; 166(11):1024-5. PubMed ID: 15049242
    [No Abstract]   [Full Text] [Related]  

  • 9. Development of thyroid diseases in the treatment of chronic hepatitis C with alpha-interferon may be a good prognosticator in achieving a sustained virological response: a meta-analysis.
    Tran HA; Malcolm Reeves GE; Gibson R; Attia JR
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1163-8. PubMed ID: 19682190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Celiac disease in chronic hepatitis C patients under pegylated-interferon plus ribavirin treatment. Preliminary results of a prospective single center study.
    Elefsiniotis IS; Fotos NV; Pantazis KD; Papadeli D; Mavrogiannis C
    Hepatogastroenterology; 2007; 54(75):2 p preceding table of contents. PubMed ID: 17591034
    [No Abstract]   [Full Text] [Related]  

  • 11. Celiac disease manifested during the treatment of chronic hepatitis C by pegylated alpha interferon and ribavirin.
    Gombosova L; Jarcuska P; Benova B; Benicky M; Lazurova I
    Bratisl Lek Listy; 2011; 112(6):360-2. PubMed ID: 21692415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-ribavirin-associated ischemic colitis.
    Punnam SR; Pothula VR; Gourineni N; Punnam A; Ranganathan V
    J Clin Gastroenterol; 2008 Mar; 42(3):323-5. PubMed ID: 18223489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depression in chronic hepatitis: the virus, the drug, or the ethnic background?
    Ferenci P; Staufer K
    Liver Int; 2008 Apr; 28(4):429-31. PubMed ID: 18339069
    [No Abstract]   [Full Text] [Related]  

  • 14. Onset of coeliac disease during treatment with interferon for chronic hepatitis C.
    Cammarota G; Cuoco L; Cianci R; Pandolfi F; Gasbarrini G
    Lancet; 2000 Oct; 356(9240):1494-5. PubMed ID: 11081540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should routine screening for celiac disease be considered before starting interferon/ribavirin treatment in patients affected by chronic hepatitis C or not?
    Nejad MR; Alavian SM
    Bratisl Lek Listy; 2012; 113(4):251. PubMed ID: 22502761
    [No Abstract]   [Full Text] [Related]  

  • 16. Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy.
    Chuang WL; Dai CY; Chang WY; Lee LP; Lin ZY; Chen SC; Hsieh MY; Wang LY; Yu ML
    Antivir Ther; 2005; 10(1):125-33. PubMed ID: 15751770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy of combined antiviral therapy with interferon alfa and ribavirin in chronic hepatitis C patients with extrahepatic manifestations].
    Zarebska-Michaluk D; Lebensztejn DM; Kryczka W
    Przegl Epidemiol; 2007; 61(3):551-8. PubMed ID: 18069393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thyrotoxicosis due to long-term therapy with interferon alpha in the patient with mixed chronic active hepatitis B and C].
    Vortel J; Bures J; Rejchrt S; Zivný P; Palicka V
    Vnitr Lek; 1999 May; 45(5):301-4. PubMed ID: 15641255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon and ribavirin for hepatitis C.
    TreatmentUpdate; 2000 May; 12(3):6-7. PubMed ID: 12125615
    [No Abstract]   [Full Text] [Related]  

  • 20. Thalidomide in the treatment of chronic hepatitis C unresponsive to alfa-interferon and ribavirin.
    Milazzo L; Biasin M; Gatti N; Piacentini L; Niero F; Zanone Poma B; Galli M; Moroni M; Clerici M; Riva A
    Am J Gastroenterol; 2006 Feb; 101(2):399-402. PubMed ID: 16454849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.